Contributors
Lusana Ahsan, Amirfarbod Yazdanyar, Marcelo Amar, Akira Hara(Gifu University), Godfrey S. Getz(University of Chicago), Katsunori Ikewaki(National Defense Medical College Hospital), Alice Ossoli(University of Milan), Bela F. Asztalos(Tufts University), Boris Vaisman(National Institutes of Health), Scott M. Gordon(University of Kentucky), Lita A. Freeman(National Institutes of Health), Catherine A. Reardon(University of Chicago), Makoto Ayaori(National Defense Medical College Hospital), Xian‐Cheng Jiang(ENN (China)), Bharti Mackness, Robert D. Shamburek(National Institutes of Health), Mike Mackness(University of Manchester), Zhiqiang Li(SUNY Downstate Health Sciences University), Toshiyuki Matsunaga(Gifu Pharmaceutical University), Alan T. Remaley(National Institutes of Health), Akira Matsunaga, Brian Y. Ishida, Mariko Tani, Mari Tabuchi, Elise F. Villard(Sanofi (France)), Maryse Guérin, Tsugikazu Komoda, Akihiro Inazu(Kanazawa University)
Cited by 0
Related Papers
Triglyceride-rich lipoproteins and their remnants: metabolic insights, role in atherosclerotic cardiovascular disease, and emerging therapeutic strategies—a consensus statement from the European Atherosclerosis Society
|European Heart Journal|2021|889
Increased High-Density Lipoprotein Levels Caused by a Common Cholesteryl-Ester Transfer Protein Gene Mutation
|New England Journal of Medicine|1990|865
Molecular basis of lipid transfer protein deficiency in a family with increased high-density lipoproteins
|Nature|1989|465
Interferences from blood collection tube components on clinical chemistry assays
|Biochemia Medica|2014|301